Anthropic's anticipated Nasdaq IPO, now eyed for November 2026 after a delay from October, underpins trader focus on ticker selection amid a confidential S-1 filing and private-market valuation near $1.34 trillion. The $ANTH outcome leads at 37.5% implied probability because it aligns directly with the company's name, a pattern seen in prior tech debuts, while shorter or less intuitive alternatives like $ANT or $APBC trail as markets price in conventional abbreviation preferences. Recent revenue run-rate guidance above $110 billion and underwriter involvement from Morgan Stanley have reinforced IPO momentum without altering ticker speculation, leaving room for last-minute regulatory or exchange-driven shifts before listing.